• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过短暂性渗透改变大鼠血脑屏障将人α干扰素递送至脑内。

Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.

作者信息

Greig N H, Fredericks W R, Holloway H W, Soncrant T T, Rapoport S I

机构信息

Laboratory of Neurosciences, National Institute on Aging, Bethesda, Maryland.

出版信息

J Pharmacol Exp Ther. 1988 May;245(2):581-6.

PMID:3367308
Abstract

Pharmacokinetic parameters of human lymphoblastoid interferon (IFN-alpha) delivery to normal rat brain were examined. IFN-alpha concentrations in brain parenchyma could only be detected 120 min after its intravascular administration, and were 0.003% per gram of the administered dose. The mean cerebrovascular permeability-surface area (permeability x surface area) product to IFN, 120 min after infusion, was 0.35 x 10(-6) sec-1, which is not significantly different from zero. Neither i.v. nor intracarotid IFN-alpha administration significantly affected delivery to brain. Intrathecal administration of IFN-alpha, via the cisterna magna, resulted in undetectable concentrations in brain tissue and plasma at 30 and 60 min. However, osmotic blood-brain barrier opening significantly increased IFN-alpha delivery to brain after its carotid administration. A maximum concentration of 0.18% per gram of the total administered dose was achieved at 120 min, and the cerebrovascular permeability-surface area was increased to 30.8 x 10(-6) sec-1. Intracerebral IFN-alpha concentrations did not decline significantly during the 240 min study. Osmotic blood-brain barrier opening increased the area under the brain concentration vs. time curve, measured between 30 and 240 min, from 0.012 x 10(6) U.min/g, in controls, to 1.24 x 10(6) U.min/g, at least 100-fold. This study indicates that osmotic blood-brain barrier opening significantly increases the delivery of IFN-alpha into brain, and that delivered remains within the brain for many hours.

摘要

研究了人淋巴母细胞干扰素(IFN-α)向正常大鼠脑内递送的药代动力学参数。血管内给药120分钟后,仅在脑实质中检测到IFN-α浓度,每克给药剂量中为0.003%。输注120分钟后,脑血管通透性-表面积(通透性×表面积)乘积对IFN而言为0.35×10⁻⁶秒⁻¹,与零无显著差异。静脉注射或颈动脉注射IFN-α均未显著影响其向脑内的递送。通过枕大池鞘内注射IFN-α,在30分钟和60分钟时脑组织和血浆中浓度均检测不到。然而,渗透性血脑屏障开放显著增加了颈动脉给药后IFN-α向脑内的递送。在120分钟时,每克总给药剂量达到最大浓度0.18%,脑血管通透性-表面积增加到30.8×10⁻⁶秒⁻¹。在240分钟的研究期间,脑内IFN-α浓度未显著下降。渗透性血脑屏障开放使30至240分钟期间测量的脑浓度-时间曲线下面积从对照组的0.012×10⁶单位·分钟/克增加到1.24×10⁶单位·分钟/克,至少增加了100倍。本研究表明,渗透性血脑屏障开放显著增加了IFN-α向脑内的递送,且递送的IFN-α在脑内可保持数小时。

相似文献

1
Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.通过短暂性渗透改变大鼠血脑屏障将人α干扰素递送至脑内。
J Pharmacol Exp Ther. 1988 May;245(2):581-6.
2
Plasma and tissue pharmacokinetics of human interferon-alpha in the rat after its intravenous administration.人α-干扰素静脉注射后在大鼠体内的血浆和组织药代动力学
J Pharmacol Exp Ther. 1988 May;245(2):574-80.
3
Osmotic opening of the blood-brain barrier to methotrexate in the rat.大鼠血脑屏障对甲氨蝶呤的渗透性开放
Surg Neurol. 1979 Oct;12(4):323-8.
4
Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.大鼠脑肿瘤经颈动脉给药后,在未开放和开放血脑屏障及血肿瘤屏障(通过高渗方法)的情况下,肿瘤细胞对[14C]甲氨蝶呤的药代动力学:一项定量放射自显影研究。
Cancer Res. 1988 Feb 1;48(3):694-701.
5
Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
Cancer Res. 1981 Nov;41(11 Pt 1):4466-70.
6
Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.通过颈内动脉输注癸酸钠实现大鼠血脑屏障的分级可逆开放。
J Neurosci Methods. 2008 Mar 15;168(2):443-9. doi: 10.1016/j.jneumeth.2007.11.004. Epub 2007 Nov 19.
7
Central nervous system distribution kinetics of indinavir in rats.茚地那韦在大鼠中枢神经系统的分布动力学
J Pharm Pharmacol. 2007 Aug;59(8):1077-85. doi: 10.1211/jpp.59.8.0004.
8
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.利用渗透性血脑屏障破坏将黑色素瘤相关免疫球蛋白单克隆抗体和Fab片段递送至正常脑组织。
Cancer Res. 1988 Sep 1;48(17):4725-9.
9
NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.美国国家毒理学计划关于邻苯二甲酸二丁酯(化学物质登记号84 - 74 - 2)经饲料给予F344/N大鼠和B6C3F1小鼠的毒性研究技术报告。
Toxic Rep Ser. 1995 Apr;30:1-G5.
10
Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.
Cancer Res. 1983 Nov;43(11):5278-85.

引用本文的文献

1
Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer's Disease and Geriatric Depression.吲哚胺2,3-双加氧酶作为阿尔茨海默病和老年抑郁症的治疗靶点
Brain Sci. 2023 May 24;13(6):852. doi: 10.3390/brainsci13060852.
2
Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.脑疾病中血脑屏障的演变及相关系统性纳米级脑靶向给药策略
Acta Pharm Sin B. 2021 Aug;11(8):2306-2325. doi: 10.1016/j.apsb.2020.11.023. Epub 2020 Dec 31.
3
Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer's disease.
阿尔茨海默病大鼠模型中干扰素-β1a(IFNβ1a)的抗炎和认知作用。
J Neuroinflammation. 2019 Feb 18;16(1):44. doi: 10.1186/s12974-019-1417-4.
4
Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.阿尔茨海默病的脑部药物递送:血脑屏障的考虑。
Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.
5
Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.血脑屏障的渗透性开放:原理、机制及治疗应用
Cell Mol Neurobiol. 2000 Apr;20(2):217-30. doi: 10.1023/a:1007049806660.
6
Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.
Clin Exp Metastasis. 1993 Mar;11(2):131-40. doi: 10.1007/BF00114971.
7
Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain.
Cancer Chemother Pharmacol. 1990;25(5):320-5. doi: 10.1007/BF00686230.